These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9425529)

  • 1. Parallel increase of heterochromatic increment threshold and postadaptation thresholds in Parkinson's disease and in neuroleptic treatment.
    Haug BA; Hermsteiner EM; Bandelow B; Paulus W
    Vision Res; 1997 Dec; 37(24):3535-47. PubMed ID: 9425529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of retinal increment thresholds in Huntington's disease.
    Paulus W; Schwarz G; Werner A; Lange H; Bayer A; Hofschuster M; Müller N; Zrenner E
    Ann Neurol; 1993 Oct; 34(4):574-8. PubMed ID: 8215245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient tritanopia in migraine: evidence for a large-field retinal abnormality in blue-yellow opponent pathways.
    Tibber MS; Shepherd AJ
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5125-31. PubMed ID: 17065534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red light increment threshold as a measure of deficient color vision.
    York YC; Loop MS
    Optom Vis Sci; 2008 Feb; 85(2):106-11. PubMed ID: 18296927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ageing on postreceptoral short-wavelength gain control: transient tritanopia increases with age.
    Werner A; Bayer A; Schwarz G; Zrenner E; Paulus W
    Vision Res; 2010 Aug; 50(17):1641-8. PubMed ID: 20457174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual dysfunction in Parkinson's disease.
    Rodnitzky RL
    Clin Neurosci; 1998; 5(2):102-6. PubMed ID: 10785835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classical tritanopia.
    Alpern M; Kitahara K; Krantz DH
    J Physiol; 1983 Feb; 335():655-81. PubMed ID: 6603508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive plasticity during the development of colour vision.
    Wagner HJ; Kröger RH
    Prog Retin Eye Res; 2005 Jul; 24(4):521-36. PubMed ID: 15845347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual and visual cognitive dysfunction in Parkinson's disease: spatial and chromatic vision.
    Bodis-Wollner IG; Paulus W
    Adv Neurol; 1999; 80():383-8. PubMed ID: 10410745
    [No Abstract]   [Full Text] [Related]  

  • 11. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
    Flanagan P; Zele AJ
    Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Color and luminance increment thresholds in poor readers.
    Dain SJ; Floyd RA; Elliot RT
    Vis Neurosci; 2008; 25(3):481-6. PubMed ID: 18598422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Color discrimination thresholds following adaptation to different saturation levels of color fields in anomalous trichromats].
    Rabkin EB; Sokolova EG; Loseva I
    Dokl Akad Nauk SSSR; 1976; 228(1):242-3. PubMed ID: 1084263
    [No Abstract]   [Full Text] [Related]  

  • 14. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
    Coelho M; Ferreira J; Rosa M; Sampaio C
    Expert Opin Pharmacother; 2008 Mar; 9(4):523-35. PubMed ID: 18312155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color stimuli perception in presence of light scattering.
    Ozolinsh M; Colomb M; Ikaunieks G; Karitans V
    Vis Neurosci; 2006; 23(3-4):597-601. PubMed ID: 16962002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential thresholds of the light wave length depending on color adaptation].
    Tuliszka M; Kedzia B; Kokowska U
    Klin Oczna; 1983; 85(1):23-4. PubMed ID: 6876660
    [No Abstract]   [Full Text] [Related]  

  • 18. Latitude-of-birth and season-of-birth effects on human color vision in the Arctic.
    Laeng B; Brennen T; Elden A; Gaare Paulsen H; Banerjee A; Lipton R
    Vision Res; 2007 Jun; 47(12):1595-607. PubMed ID: 17451775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of anti-epileptic drugs on visual perception in patients with epilepsy.
    Paulus W; Schwarz G; Steinhoff BJ
    Brain; 1996 Apr; 119 ( Pt 2)():539-49. PubMed ID: 8800947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a chromatometer: a new method for blue-yellow or green-red visual comparisons, and anomaly screening techniques.
    Gaudart J; Pétrakian JP
    Med Sci Monit; 2005 Aug; 11(8):MT39-52. PubMed ID: 16049389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.